These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15911913)

  • 21. Association of anthropometric measures with the presence and progression of benign prostatic hyperplasia.
    Burke JP; Rhodes T; Jacobson DJ; McGree ME; Roberts RO; Girman CJ; Lieber MM; Jacobsen SJ
    Am J Epidemiol; 2006 Jul; 164(1):41-6. PubMed ID: 16611664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnosis of infravesical obstruction in patients with benign prostatic hyperplasia].
    Al'-Shukri SKh; Amdiĭ RE
    Urologiia; 2006; (2):41-3, 45. PubMed ID: 16708588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticholinergic therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia.
    Gallegos PJ; Frazee LA
    Pharmacotherapy; 2008 Mar; 28(3):356-65. PubMed ID: 18294115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alfuzosin 10 mg once daily prevents overall clinical progression of benign prostatic hyperplasia but not acute urinary retention: results of a 2-year placebo-controlled study.
    Roehrborn CG
    BJU Int; 2006 Apr; 97(4):734-41. PubMed ID: 16536764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Turbulent urinary flow in the urethra could be a causal factor for benign prostatic hyperplasia.
    Martinez-Borges AR
    Med Hypotheses; 2006; 67(4):871-5. PubMed ID: 16764996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective randomized trial comparing transurethral prostatic resection and clean intermittent self-catheterization in men with chronic urinary retention.
    Ghalayini IF; Al-Ghazo MA; Pickard RS
    BJU Int; 2005 Jul; 96(1):93-7. PubMed ID: 15963128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of 25 and 75 mg/day naftopidil for lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective, randomized controlled study.
    Yokoyama T; Kumon H; Nasu Y; Takamoto H; Watanabe T
    Int J Urol; 2006 Jul; 13(7):932-8. PubMed ID: 16882058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic and predictive value of voiding diary data versus prostate volume, maximal free urinary flow rate, and Abrams-Griffiths number in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    van Venrooij GE; van Melick HH; Eckhardt MD; Boon TA
    Urology; 2008 Mar; 71(3):469-74. PubMed ID: 18342189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The ICS-'BPH' Study: the psychometric validity and reliability of the ICSmale questionnaire.
    Donovan JL; Abrams P; Peters TJ; Kay HE; Reynard J; Chapple C; De La Rosette JJ; Kondo A
    Br J Urol; 1996 Apr; 77(4):554-62. PubMed ID: 8777617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychological effects of an epidemiological study of benign prostatic hypertrophy.
    McIntosh IB; Power KG; Simpson RJ
    Br J Clin Pract; 1994; 48(3):118-21. PubMed ID: 7518240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dutasteride significantly improves quality of life measures in patients with enlarged prostate.
    O'Leary MP; Roehrborn CG; Black L
    Prostate Cancer Prostatic Dis; 2008; 11(2):129-33. PubMed ID: 17592479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tolterodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Kaplan SA; Walmsley K; Te AE
    J Urol; 2005 Dec; 174(6):2273-5. discussion 2275-6. PubMed ID: 16280803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. When to investigate benign prostatic hyperplasia.
    Thomas D
    Practitioner; 1997 Jul; 241(1576):408-13. PubMed ID: 9425714
    [No Abstract]   [Full Text] [Related]  

  • 34. Urodynamic predictors of outcomes with photoselective laser vaporization prostatectomy in patients with benign prostatic hyperplasia and preoperative retention.
    Monoski MA; Gonzalez RR; Sandhu JS; Reddy B; Te AE
    Urology; 2006 Aug; 68(2):312-7. PubMed ID: 16904443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
    Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N
    BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 ml or greater.
    Kaplan SA; McConnell JD; Roehrborn CG; Meehan AG; Lee MW; Noble WR; Kusek JW; Nyberg LM;
    J Urol; 2006 Jan; 175(1):217-20; discussion 220-1. PubMed ID: 16406915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary retention and post-void residual urine in men: separating truth from tradition.
    Kaplan SA; Wein AJ; Staskin DR; Roehrborn CG; Steers WD
    J Urol; 2008 Jul; 180(1):47-54. PubMed ID: 18485378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphisms in genes involved in sex hormone metabolism may increase risk of benign prostatic hyperplasia.
    Roberts RO; Bergstralh EJ; Farmer SA; Jacobson DJ; Hebbring SJ; Cunningham JM; Thibodeau SN; Lieber MM; Jacobsen SJ
    Prostate; 2006 Mar; 66(4):392-404. PubMed ID: 16302261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of sexual function in men with symptomatic benign prostatic hyperplasia].
    Shao Q; Song J; Guo YW; Lu WC; Du LD
    Zhonghua Nan Ke Xue; 2005 Jul; 11(7):505-7. PubMed ID: 16078666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of benign prostatic hyperplasia disease.
    Marks LS; Roehrborn CG; Andriole GL
    J Urol; 2006 Oct; 176(4 Pt 1):1299-306. PubMed ID: 16952616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.